On February 17, Xu Renbiao, member of the Standing Committee of the Taizhou Municipal Party Committee and Secretary of the Wenling Municipal Party Committee, visited Wanbangde Pharmaceutical to investigate and guide the company's work resumption and epidemic prevention and control during the prevention and control of the new coronavirus pneumonia.

Secretary Xu Renbiao learned in detail about the epidemic prevention and control measures of Wanbangde Pharmaceutical and the resumption of work and production of the company, and carefully asked about the difficulties and problems the company is currently facing. "Where do the workers returning to work come from, and how do non-local workers plan to return to work?" "Are masks and other protective materials sufficient?" "What safety measures have you taken to resume work?" Secretary Xu Renbiao had an in-depth conversation with Chairman Zhao Shouming.

Chairman Zhao Shouming made a report on relevant issues. Wanbangde Pharmaceutical has gradually resumed production since February 10. As of now, 30% of the total employees who have resumed work are employees from Wenling. For employees with more concentrated origins in other provinces, the company will take them back in batches by chartered vehicles and place them in hotels and some staff dormitories for isolation and observation. He said that in order to do a good job in resuming work and production during the epidemic prevention and control period, the company issued an epidemic prevention work plan and established a leading group for the prevention and control of the new coronavirus infection pneumonia epidemic. The chairman of the company serves as the team leader, the members of the leadership team serve as the deputy team leaders, and the deputy general managers of each branch pipeline and the heads of various departments, workshop directors, and key post personnel serve as members, with clear responsibilities, responsible for the company's epidemic prevention and control and emergency response Work. In order to ensure the safety of employees, the company establishes employee health files, implements "one person, one file" management, and starts from protective measures, employee epidemic prevention and control knowledge training, epidemic prevention knowledge publicity, temperature monitoring, box lunch distribution, isolation monitoring, and strict supervision. Focus on epidemic prevention in one hand and production in the other, so that both epidemic prevention and production are correct. At this stage, the company has reserved a batch of medical masks and a batch of disinfectant, alcohol and other protective materials.

Secretary Xu Renbiao emphasized that in the face of major epidemics, Wanbangde Pharmaceuticals should play a pioneering and leading role as a listed company, strictly implement the main responsibility for prevention and control, and take the safety and health of employees as the primary goal. When resuming work and production, it is necessary to ensure that prevention and control measures are in place, personnel information is in place, internal safety management is in place, and protective materials are in place. Production workshops, office buildings, staff restaurants, staff dormitories and other areas must be regularly sterilized to enhance employees’ self-protection awareness. , to ensure that safety risks are always under control during the epidemic.

Afterwards, Secretary Xu Renbiao highly praised Wanbond for actively fulfilling its social responsibility, dedicating love, and using overseas market channels to urgently purchase 78,500 N95 masks and more than 100 temperature measuring guns to help Taizhou and Wenling fight the epidemic during the epidemic prevention and control period. At the same time, it is hoped that Wanbangde will continue to devote itself to social welfare undertakings in the future development and demonstrate its corporate responsibility.

Secretary Xu Renbiao also inquired carefully about the work that Wanbangde Pharmaceutical has carried out in the scientific research to combat the new crown virus pneumonia epidemic. Chairman Zhao Shouming introduced that on February 13, Zhejiang Provincial Food and Drug Administration and Zhejiang Provincial Health Commission organized expert review and approved Wanbangde Bromhexine Hydrochloride Tablets to carry out emergency clinical scientific research and innovative application research for the treatment of pneumonia caused by new coronavirus infection. The project has been launched urgently, led by the Second Affiliated Hospital of Wenzhou Medical University, with the full cooperation of Wanbangde Pharmaceutical, and related drug research work is progressing in an orderly manner. Secretary Xu Renbiao urged that companies must count against every second to carry out clinical scientific research and innovative applications of the new coronavirus infection pneumonia epidemic, so as to contribute to winning the battle against the epidemic.

In the end, Secretary Xu Renbiao asked the relevant departments to set up a special work class to optimize the approval procedures for the problems encountered in the industrial development raised by the enterprise, and to implement a special person responsible for Wanbangde-related projects, provide good services, and help coordinate and solve the problems encountered in the development of the enterprise. difficulties and problems.